| 86R1341 KKR-D  
---|---  
|  By: Hinojosa | H.B. No. 30  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to the transfer of unused long-acting reversible  
| contraceptive products under Medicaid and the Healthy Texas Women  
| program.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Subchapter B, Chapter 531, Government Code, is  
| amended by adding Section 531.0742 to read as follows:  
|  _Sec._ ___531.0742._ _____TRANSFER OF UNUSED LONG-ACTING REVERSIBLE_  
| _CONTRACEPTIVE PRODUCT. (a) In this section:_  
|  _(1)_ _____"Healthy Texas Women program" means a program_  
| _operated by the commission that is substantially similar to the_  
| _demonstration project operated under former Section 32.0248, Human_  
| _Resources Code, and that is intended to expand access to preventive_  
| _health and family planning services for women in this state._  
|  _(2)_ _____"Long-acting reversible contraceptive product"_  
| _means a method of birth control that provides effective_  
| _contraception for an extended period without requiring user action._  
| _The term includes an injection, intrauterine device, and subdermal_  
| _contraceptive implant._  
|  _(b)_ _____In accordance with commission rules, a health care_  
| _provider under Medicaid or the Healthy Texas Women program may_  
| _transfer to a Medicaid or Healthy Texas Women program recipient a_  
| _long-acting reversible contraceptive product prescribed by the_  
| _provider to another recipient if:_  
|  _(1) the long-acting reversible contraceptive product:_  
|  _(A)_ _____was not delivered to or used by the recipient_  
| _to whom the contraceptive product was initially prescribed;_  
|  _(B)_ _____is contained in the contraceptive product's_  
| _original packaging and that packaging is unopened; and_  
|  _(C)_ _____is prescribed to and is medically appropriate_  
| _and not contraindicated for the recipient to whom the contraceptive_  
| _product is being transferred; and_  
|  _(2) at the time of the transfer:_  
|  _(A)_ _____the contraceptive product has been in the_  
| _health care provider's possession for at least 12 weeks following_  
| _the date of the original prescription for the product; or_  
|  _(B)_ _____the health care provider has written_  
| _confirmation that the recipient to whom the contraceptive product_  
| _was initially prescribed no longer wishes to receive or use the_  
| _product._  
|  SECTION 2. Not later than March 31, 2020, the executive  
| commissioner of the Health and Human Services Commission shall  
| adopt rules necessary to implement Section 531.0742, Government  
| Code, as added by this Act.  
|  SECTION 3. If before implementing any provision of this Act  
| a state agency determines that a waiver or authorization from a  
| federal agency is necessary for implementation of that provision,  
| the agency affected by the provision shall request the waiver or  
| authorization and may delay implementing that provision until the  
| waiver or authorization is granted.  
|  SECTION 4. This Act takes effect September 1, 2019.

